Skip Navigation

Two-Part, Phase IA/B, Open-Label, Multicenter Trial Evaluating Pharmacokinetics, Safety and Efficacy Of Pf-07284890 Arry-461 In Participants with BRAF V600-Mutant Solid Tumors with And Without Brain Involvement

Brief Summary

Type:
Other

Study Type:
Treatment

Phase:
I

ClinicalTrials.gov Identifier:
NCT04543188

Study #:
STUDY00146681

Start Date:
Jul 14, 2022

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT04543188

View Complete Trial Details & Eligibility at ClinicalTrials.gov